{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T19:31:08Z","timestamp":1769974268059,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jns.2024.123155","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T22:20:15Z","timestamp":1722464415000},"page":"123155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Clinical and molecular predictors of survival among atypical parkinsonian syndromes in a North African tertiary referral center"],"prefix":"10.1016","volume":"464","author":[{"given":"Ikram","family":"Sghaier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Nasri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Atrous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssef","family":"Abida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alya","family":"Gharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira","family":"Souissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saloua","family":"Mrabet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouna","family":"Ben Djebara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Kacem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Gargouri-Berrechid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riadh","family":"Gouider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2024.123155_bb0005","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-023-11807-x","article-title":"Neurological update: non-motor symptoms in atypical parkinsonian syndromes","author":"Ananthavarathan","year":"2023","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2024.123155_bb0010","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1002\/hbm.26342","article-title":"Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndrome","volume":"44","author":"Whiteside","year":"2023","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.jns.2024.123155_bb0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.parkreldis.2020.10.003","article-title":"How specific are non-motor symptoms in the prodrome of Parkinson\u2019s disease compared to other movement disorders?","volume":"81","author":"Moscovich","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.jns.2024.123155_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-022-00329-4","article-title":"Factors associated with mortality in early stages of parkinsonism","volume":"8","author":"van Rumund","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.jns.2024.123155_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104813","article-title":"Disease progression and prognostic factors in multiple system atrophy: a prospective cohort study","volume":"139","author":"Foubert-Samier","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2024.123155_bb0030","first-page":"66","article-title":"Corticobasal degeneration and corticobasal syndrome: a review","volume":"1","author":"Constantinides","year":"2019","journal-title":"Clin. Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.jns.2024.123155_bb0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3233\/JPD-2012-11056","article-title":"Difference in MSA phenotype distribution between populations: genetics or environment?","volume":"2","author":"Ozawa","year":"2012","journal-title":"J. Parkinsons Dis."},{"issue":"2","key":"10.1016\/j.jns.2024.123155_bb0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-045100","article-title":"Multiple system atrophy in Hokkaido, Japan: a prospective registry study of natural history and symptom assessment scales followed for 5 years","volume":"11","author":"Matsushima","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jns.2024.123155_bb0045","doi-asserted-by":"crossref","DOI":"10.14802\/jmd.23178","article-title":"Phenotypic spectrum of progressive supranuclear palsy: clinical study and APOE effect","author":"Nasri","year":"2024","journal-title":"J. Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2024.123155_bb0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.jns.2024.123155_bb0055","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1128\/AAC.48.8.2787-2792.2004","article-title":"Hazard ratio in clinical trials","volume":"48","author":"Spruance","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jns.2024.123155_bb0060","series-title":"StatPearls","article-title":"Parkinson-plus syndrome","author":"Vertes","year":"2024"},{"key":"10.1016\/j.jns.2024.123155_bb0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.arr.2019.01.005","article-title":"Survival time and differences between dementia with Lewy bodies and Alzheimer\u2019s disease following diagnosis: a meta-analysis of longitudinal studies","volume":"50","author":"Mueller","year":"2019","journal-title":"Ageing Res. Rev."},{"issue":"12","key":"10.1016\/j.jns.2024.123155_bb0070","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S1474-4422(09)70288-1","article-title":"Multiple system atrophy: an update","volume":"8","author":"Stefanova","year":"2009","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.jns.2024.123155_bb0075","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mds.21839","article-title":"Survival in multiple system atrophy","volume":"23","author":"Schrag","year":"2008","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.jns.2024.123155_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202044","article-title":"Relative survival in patients with dementia with Lewy bodies and Parkinson\u2019s disease dementia","volume":"13","author":"Larsson","year":"2018","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jns.2024.123155_bb0085","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000107703","article-title":"Predictors of survival in dementia with lewy bodies and Parkinson dementia","volume":"4","author":"Jellinger","year":"2007","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.jns.2024.123155_bb0090","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9421098","article-title":"REM sleep behavior disorder (RBD) in dementia with Lewy bodies (DLB)","volume":"2018","author":"Chan","year":"2018","journal-title":"Behav. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2024.123155_bb0095","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.5665\/sleep.6016","article-title":"Mortality and its risk factors in patients with rapid eye movement sleep behavior disorder","volume":"39","author":"Zhou","year":"2016","journal-title":"Sleep"},{"issue":"8","key":"10.1016\/j.jns.2024.123155_bb0100","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/mds.29077","article-title":"Disease progression in multiple system atrophy\u2014novel modeling framework and predictive factors","volume":"37","author":"K\u00fchnel","year":"2022","journal-title":"Mov. Disord."},{"issue":"Pt 5","key":"10.1016\/j.jns.2024.123155_bb0105","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/brain\/awf117","article-title":"Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients","volume":"125","author":"Watanabe","year":"2002","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2024.123155_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-022-00413-9","article-title":"Laboratory prognostic factors for the long-term survival of multiple system atrophy","volume":"8","author":"Shin","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"issue":"8","key":"10.1016\/j.jns.2024.123155_bb0115","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/ene.15347","article-title":"Tracheostomy is associated with increased survival in multiple system atrophy patients with stridor","volume":"29","author":"Giannini","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"13","key":"10.1016\/j.jns.2024.123155_bb0120","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1212\/WNL.0000000000003156","article-title":"Early stridor onset and stridor treatment predict survival in 136 patients with MSA","volume":"87","author":"Giannini","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2024.123155_bb0125","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/1531-8257(200007)15:4<699::AID-MDS1015>3.0.CO;2-L","article-title":"Stridor and death in multiple system atrophy","volume":"15","author":"Silber","year":"2000","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2024.123155_bb0130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.14336\/AD.2017.0711","article-title":"Causes of death in Chinese patients with multiple system atrophy","volume":"9","author":"Zhang","year":"2018","journal-title":"Aging Dis."},{"issue":"14","key":"10.1016\/j.jns.2024.123155_bb0135","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1212\/WNL.0000000000008208","article-title":"Stridor in multiple system atrophy: consensus statement on diagnosis, prognosis, and treatment","volume":"93","author":"Cortelli","year":"2019","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.jns.2024.123155_bb0140","doi-asserted-by":"crossref","first-page":"e1828","DOI":"10.1212\/WNL.0000000000009372","article-title":"Progression and prognosis in multiple system atrophy presenting with REM behavior disorder","volume":"94","author":"Giannini","year":"2020","journal-title":"Neurology"},{"issue":"18","key":"10.1016\/j.jns.2024.123155_bb0145","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000002638","article-title":"Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes","volume":"86","author":"Coyle-Gilchrist","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123155_bb0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.parkreldis.2021.01.015","article-title":"Association of PSP phenotypes with survival: a brain-bank study","volume":"84","author":"Guasp","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5","key":"10.1016\/j.jns.2024.123155_bb0155","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/jnnp-2016-314956","article-title":"Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis","volume":"88","author":"Glasmacher","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2024.123155_bb0160","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/mds.29299","article-title":"Using downgaze palsy progression rate to model survival in progressive Supranuclear palsy-Richardson syndrome","volume":"38","author":"Xie","year":"2023","journal-title":"Mov. Disord."},{"issue":"46","key":"10.1016\/j.jns.2024.123155_bb0165","doi-asserted-by":"crossref","first-page":"80941","DOI":"10.18632\/oncotarget.20895","article-title":"Brain gray matter abnormalities in progressive supranuclear palsy revisited","volume":"8","author":"Pan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jns.2024.123155_bb0170","doi-asserted-by":"crossref","unstructured":"El-Wahsh S, Finger EC, Piguet O, et al. Predictors of survival in frontotemporal lobar degeneration syndromes. J. Neurol. Neurosurg. Psychiatry Published online January 13, 2021:jnnp-2020-324349. doi:https:\/\/doi.org\/10.1136\/jnnp-2020-324349.","DOI":"10.1136\/jnnp-2020-324349"},{"issue":"2","key":"10.1016\/j.jns.2024.123155_bb0175","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/jnnp.64.2.184","article-title":"Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination","volume":"64","author":"Wenning","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2024.123155_bb0180","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","article-title":"APOE in the Bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases","volume":"17","author":"Fern\u00e1ndez-Calle","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.jns.2024.123155_bb0185","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/WNL.57.1.138","article-title":"Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsy","volume":"57","author":"Litvan","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2024.123155_bb0190","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1474-9726.2011.00778.x","article-title":"A neuroprotective role for the DNA damage checkpoint in tauopathy","volume":"11","author":"Khurana","year":"2012","journal-title":"Aging Cell"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24002909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24002909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T21:20:37Z","timestamp":1724534437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24002909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":38,"alternative-id":["S0022510X24002909"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123155","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and molecular predictors of survival among atypical parkinsonian syndromes in a North African tertiary referral center","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123155"}}